Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | +2.34% | +1.55% | +122.03% |
Chart calendar DURECT Corporation
Upcoming events on DURECT Corporation
Past events on DURECT Corporation
2024-06-08 08:30 am | European Association for the Study of the Liver Congress - Abstract No. LB73 |
2024-05-13 04:30 pm | Q1 2024 Earnings Call |
2024-05-13 04:05 pm | Q1 2024 Earnings Release |
2024-03-27 04:30 pm | Q4 2023 Earnings Call |
2024-03-27 04:05 pm | Q4 2023 Earnings Release |
2024-02-14 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
2023-11-13 04:30 pm | Q3 2023 Earnings Call |
2023-11-13 04:05 pm | Q3 2023 Earnings Release |
2023-11-07 05:00 pm | Business Update Call |
2023-09-27 04:45 pm | Cantor Global Healthcare Conference |
2023-09-11 10:30 am | H.C. Wainwright Global Investment Conference |
2023-08-09 04:30 pm | Q2 2023 Earnings Call |
2023-08-09 04:05 pm | Q2 2023 Earnings Release |
2023-06-21 12:00 pm | Annual General Meeting |
2023-05-16 12:00 pm | Investor Meeting - Key Opinion Leader |
2023-05-08 04:30 pm | Q1 2023 Earnings Call |
2023-05-08 04:05 pm | Q1 2023 Earnings Release |
2023-05-02 10:00 am | H.C. Wainwright BioConnect Investor Conference |
2023-03-15 02:00 pm | Oppenheimer Healthcare Conference |
2023-03-07 04:30 pm | Q4 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 29,6 29,8 -0.84% | 30,1 40,4 -25.4% | 14,0 8,79 59.07% | 19,3 19,5 -0.91% | 8,55 8,58 -0.38% | 10,1 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -19,2 -18,2 -5.19% | -12,6 -6,40 -97.24% | -34,3 -38,3 10.59% | -35,1 -35,6 1.32% | -36,9 -40,3 8.41% | -25,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,6 -19,9 -3.36% | -14,3 -6,90 -107.67% | -36,3 -40,2 9.74% | -35,3 -37,4 5.43% | -27,6 -37,8 26.82% | -28,3 |
Net income Million USD | Released Forecast Spread | -20,6 -19,9 -3.36% | -0,58 -8,07 92.78% | -36,3 -40,2 9.74% | -35,3 -37,3 5.36% | -27,6 -37,9 27.16% | -28,8 |
EPS USD | Released Forecast Spread | -1,20 -1,14 -5.26% | 0,00 -0,40 - | -1,60 -1,80 11.11% | -1,55 -1,15 -34.78% | -1,05 -1,46 28.25% | -0,85 |
Announcement Date | 03/03/20 | 04/03/21 | 07/03/22 | 07/03/23 | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,92 2,28 -16.13% | 2,08 3,84 -45.98% | 12,0 13,0 -7.78% | 3,32 3,48 -4.78% | 2,05 3,19 -35.52% | 2,08 3,16 -34.12% | 1,74 2,52 -30.74% | 2,67 2,70 -1.22% | 1,83 2,73 -32.95% | 2,49 | 2,56 | 2,73 |
EBIT Million USD | Released Forecast Spread | -10,4 -11,9 13.21% | -11,1 -10,4 -7.1% | -2,13 -2,29 6.85% | -11,5 -12,0 3.88% | -11,0 -12,5 11.98% | -10,1 -11,2 10.09% | -9,56 -10,6 10.17% | -6,25 -9,64 35.12% | -5,72 -6,34 9.77% | -5,48 | -6,33 | -8,87 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,8 -12,3 11.79% | -11,6 -10,9 -6.27% | -2,47 -2,81 12.02% | -10,5 -12,5 16.15% | -12,0 -12,9 7.16% | -11,2 -11,7 4.18% | -3,02 -10,8 71.96% | -1,44 -8,88 83.78% | -7,64 -6,65 -15% | -5,55 | -6,45 | -9,44 |
Net income Million USD | Released Forecast Spread | -10,8 -12,3 11.79% | -11,6 -10,9 -6.27% | -2,47 -2,81 12.02% | -10,5 -12,5 16.15% | -12,0 -12,9 7.16% | -11,2 -11,7 4.18% | -3,02 -11,0 72.47% | -1,44 -9,96 85.53% | -7,64 -6,65 -15% | -5,80 | -6,69 | -9,22 |
EPS USD | Released Forecast Spread | -0,50 -0,53 6.25% | -0,50 -0,47 -7.14% | -0,10 -0,10 0% | -0,46 -0,55 15.85% | -0,50 -0,53 5.06% | -0,46 -0,48 4.83% | -0,11 -0,41 73.39% | -0,05 -0,36 86.11% | -0,25 -0,22 -13.64% | -0,17 | -0,20 | -0,26 |
Announcement Date | 04/05/22 | 04/08/22 | 02/11/22 | 07/03/23 | 08/05/23 | 09/08/23 | 13/11/23 | 27/03/24 | 13/05/24 | - | - | - |
Past sector events for DURECT Corporation
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DRRX Stock
- Calendar DURECT Corporation